The synthesis of substituted pyrazolo [3',4':4,5]thieno [2,3-d]pyrimidin-8-ones (IIIa-j) from 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile (II) is described. The key compound II was synthesized from (5-methyl--2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile I via the Gewald reaction. The synthesis of the title compounds IIIa-j was accomplished by condensation of II with different aromatic aldehydes. The newly synthesized heterocyles were characterized by elemental analysis, IR, 1 H-NMR, 13 C-NMR and mass spectroscopic investigation. All the newly synthesized compounds were evaluated for antimicrobial activity against a variety of bacterial strains.
INTRODUCTION
Pyrazole-containing compounds have practical applications in medicinal and agrochemical fields and the biological activities of pyrazoles 1,2 and its derivatives are well documented. The pyrazole ring is the basic moiety for a number of dyes, drugs and anaesthetics. 3, 4 Substituted pyrazolopyrimidinones are found to be useful as cardiotonic, 5 herbicidal 6 and antiviral 7 agents. A literature survey revealed that substituted pyrazolopyrimidinones are potent and selective inhibitors of type 5 cyclic guanosine-3',5'-monophosphate phosphodiesterase (cGMP) PDE-5 8, 9 and, as such, have utility in the treatment of male erectile dysfunction (MED) and female sexual dysfunction (FSD). 10 C-6 substituted pyrimidinone and pyrimidinedione derivatives showed selective antitumour, 11 antiviral, 12 antitubercular 13 and antifungal activity, 14 suggesting the importance of testing this family of compounds as broad-spectrum drugs.
In the search of bioactive molecules and in continuation of previous work on the development of syntheses of polyfunctionally substituted heterocyclic com-pounds, a novel synthetic approach for the synthesis of 6-aryl-3-methyl-1,5,6,7--tetrahydro-8H-pyrazolo[3',4':4,5]thieno [2,3-d] pyrimidin-8-ones (IIIa-j) is reported herein. All the newly synthesized compounds (IIIa-j) were evaluated for their antibacterial and antifungal activity. The biological activities of the synthesized compounds were compared with reference standard drugs.
RESULTS AND DISCUSSION

Chemistry
The synthesis of 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile (II) was accomplished by refluxing (5-methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile (I) and sulphur in the presence of morpholine for 6 h using the Gewald reaction. 15 CHARACTERIZATION AND BIOLOGICAL EVALUATION OF SOME NOVEL PYRIMIDIN-8-ONES
685
The purity of the compounds was controlled by TLC. The spectral data of all the newly synthesized compounds, given below, were in full agreement with the proposed structures.
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Biological screening
Microbiology. The compounds IIIa-j were evaluated for their antimicrobial activity against Streptococcus pyogenes, Staphylococcus aureus, Escherichia coli, Bacillus subtillis and antifungal activity against Candida albicans and Aspergillus niger at a concentration of 50 µg ml -1 in DMF using the cup-plate method. 21, 22 After 24 h of incubation at 37 °C, the zones of inhibition were measured in mm. The activities were compared with those of some known antibiotics, such as ampicillin, chloramphenicol, norfloxacin and ciprofloxacin, as well as griseofulvin at the same concentration. The results are summarized in Table I . 
EXPERIMENTAL
Melting points were determined routinely in open capillaries and are uncorrected. The formation and purity of the compounds were routinely checked by TLC using silica gel-G. The spots were located under iodine vapour or UV light. The 1 H-NMR and 13 C-NMR spectra were recorded in CDCl 3 on a Brucker DRX-300 at 300 MHz using TMS as the internal standard. The mass spectra were scanned on a GCMS-QP2010 instrument.
Preparation of (5-methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile (I)
An equimolar mixture of 5-methyl-2,4-dihydro-3H-pyrazol-3-one and malononitrile was refluxed in the presence of piperidyl acetate (2-3 drops) for 6 h. The product obtained by pouring the reaction mixture into ice-cold water was filtered, dried and recrystallized from 95 % ethanol.
Preparation of 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile (II)
(5-Methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile (I) and sulphur were refluxed in the presence of morpholine (3.0 ml) for 6 h. The product obtained by pouring the reaction mixture into ice-cold water was filtered, dried and recrystallized from 95 % ethanol. General procedure for synthesis of 6-aryl-3-methyl-1,5,6,7-tetrahydro-8H-pyrazolo[3',4':4,5] thieno [2,3-d] 
pyrimidin-8-ones (IIIa-j)
An equimolar mixture of 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile (II) and an appropriate aldehyde in glacial acetic acid (20 ml) was refluxed for 6 h. The product was isolated and recrystallized from 95 % ethanol.
Antibacterial activity
The purified compounds IIIa-j were screened for their antibacterial activity. The nutrient agar, prepared in the usual manner, was inoculated specially with 0.50 ml of 24 h old subcultures of Streptococcus pyogenes, Staphylococcus aureus, Bacillus subtilius and Escherichia coli, taken in separate conical flasks at 40-50 °C, and mixed well by gentle shaking. About 25 ml of the contents of the flask were poured and evenly spread in a Petri dish (13 mm in diameter) and allowed to settle down for 2 h. The cups (10 mm in diameter) were formed with the help of a borer in the agar medium and filled with 40 µl (40 µg ml -1 ) solution of a sample in DMF. The plates were incubated at 37 °C for 24 h and the control was maintained with 40 µl of DMF in a similar manner. The zones of inhibition of bacterial growth were measured in mm. The antibacterial activity of the compounds IIIa-j was compared with known standard reference drugs, such as ampicillin, chloramphenicol, norfloxacin, ciprofloxacin at same concentration.
Antifungal activity
Aspergillus niger and Candida albicans were employed for testing the fungicidal activity using the cup plate method. The cultures were maintained on Sabouraud's agar slants. Sterilized Sabouraud's agar medium was inoculated with 0.50 ml of a 72 h old suspension of fun-gal spores from a separate flask. About 25 ml of the inoculated medium was evenly spread in a sterilized Petri dish and allowed to settle down for 2 h. The cups (10 mm in diameter) were punched in the Petri dish and loaded with 4 µl (40 µg ml -1 ) of solution of a sample in DMF. The plates were incubated at room temperature (30 °C) for 48 h. After completion of the incubation period, the zones of inhibition of growth by compounds IIIa-j were measured as the diameter in mm. Together with the test solution, one cup in each Petri dish was filled with solvent, which acted as the control. The antifungal activities of compounds IIIa-j were compared with the known standard drug griseofulvin.
CONCLUSIONS
To summarize, a new class of 6-aryl-3,6-dimethyl-1,5,6,7-tetrahydro-8H-pyrazolo[3',4':4,5]thieno[2,3-d]pyrimidin-8-ones (IIIa-h), were synthesized. The newly synthesized heterocycles exhibited moderate to promising antimicrobial activity against standard strains. These results make them interesting lead molecules for further synthetic and biological evaluation. It can be concluded that this class of compounds certainly hold great promise towards the pursuit of discovering novel classes of antimicrobial agents. Further studies to acquire more information concerning structure-activity relationships are in progress.
